Ethosuximide Capsule Breastfeeding
Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Ethosuximide Capsule while breastfeeding. We will also discuss about common side effects and warnings associated with Ethosuximide Capsule.

What is Ethosuximide Capsule used for?


Ethosuximide capsule is indicated for the control of absence (petit mal) epilepsy.

Is Ethosuximide Capsule usage safe while breastfeeding? If a lactating mother is using it can there be any effect on growth or development of infant?

Ethosuximide Capsule high risk while breastfeeding
As Ethosuximide Capsule is made of only Ethosuximide, and Ethosuximide is unsafe to use in breastfeeding we can safely reach on conclusion that Ethosuximide Capsule is also unsafe to use while breastfeeding. Below is detailed analysis of Ethosuximide and Ethosuximide Capsule during location. We recommend you to go through provided detailed analysis as below take decision accordingly. We also recommend you talk to your health care provider before making final decision.

Ethosuximide Capsule Breastfeeding Analsys


Ethosuximide while Breastfeeding

Unsafe

CAS Number: 77-67-8

Some cases of sedation and hyperexcitability and weak suction have been described. It have been reported, though, one case of two months lasting irritability and insomnia in an infant born to a mother who had taken the drug during pregnancy but did not breastfeed the child. If a pregnant woman has not been switched to other anti-convulsivant drug it would be a better option for the mother to keep-on suckling her child and follow-up the infant closely.

Ethosuximide Capsule Breastfeeding Analsys - 2


Ethosuximide while Breastfeeding

CAS Number: 77-67-8

Average ethosuximide dosages of 50 to 60% of the maternal weight-adjusted dosage are excreted in human milk and infant plasma levels of 25 to 30% of maternal levels are common. Although no adverse effects attributable solely to ethosuximide in breastmilk have been reported, monitor the infant for drowsiness, adequate weight gain, and developmental milestones, especially in younger, exclusively breastfed infants and when using combinations of anticonvulsants. Measurement of an infant serum level might help rule out toxicity if there is a concern.


What should I do if already breastfed my kid after using Ethosuximide Capsule?

We have already established that Ethosuximide Capsule is unsafe in breastfeeding and breastfeeding while using Ethosuximide Capsule is not a good idea however if have already used and then breastfed the baby then you shall monitor the behavior and health of baby closely and inform your doctor as soon as possible. In case of emergency please call 911.


I am nursing mother and my doctor has suggested me to use Ethosuximide Capsule, is it safe?

If your doctor knows that you are breastfeeding mother and still prescribes Ethosuximide Capsule then there must be good reason for that as Ethosuximide Capsule is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.


If I am using Ethosuximide Capsule, will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Ethosuximide Capsule and breastfeeding as it is considered unsafe for baby.


Who can I talk to if I have questions about usage of Ethosuximide Capsule in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients

Ethosuximide Solution
Zarontin | Ethosuximide Solution
Zarontin | Ethosuximide Capsule